Resistance Under Combinatorial Treatment In Er+ And Er- Breast Cancer.

  Address - Norway

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 10129822

  Document Type - Tender Notices

Description - Status : Grant agreement signedOverall budget : € 6 283 250EU contribution : € 6 000 000ObjectiveBreast Cancer (BC) is the first cause of cancer-related death in women worldwide. Breast cancer is classified into well-recognized molecular subtypes . Despite solid pre-clinical evidence, only some patients benefit from administering drug combinations, an indication that patient and tumor heterogeneity is still present in the current stratification. Out of the numerous possible combinations of approved drugs, only a few have been actually tried, and the choice of tested combinations has been to some degree arbitrary. This proposal seeks to develop new approaches and identify mechanisms of tre

Mt Ref Id - 10129822

Deadline - Dec 31, 2024